Healthcare -
Biotechnology - NASDAQ - US
$ 2.625
1.74 %
$ 140 M
Market Cap
-2.76
P/E
TCRX - GROSS PROFIT
Gross Profit TCRX - TScan Therapeutics, Inc.
-67.1 M
LAST VALUE
-229.38%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR